Abstract: FR-PO847
Persistent Hyperparathyroidism Post Kidney Transplantation
Session Information
- Transplantation: Clinical - Outcomes
November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Transplantation
- 2002 Transplantation: Clinical
Authors
- Arabi, Ziad, Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
- Althani, Abdullah Saleh, Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
- Aljabri, Jawaher Nayyaf, Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
- Tawhari, Mohammed Hadi, Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
- Alflaiw, Ahmad I., Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Background
Hyperparathyroidism (HPT) is a frequent complication in chronic kidney disease and may persist in 20 to 50% of cases one year after kidney transplantation; and may contribute to long term allograft dysfunction and increased risk of fractures.
There is scant data on the prevalence of post-transplant HPT in kidney transplant patients in Saudi Arabia. The aim of this study is to evaluate the prevalence of this complication and to identify its risk factors in single center in Saudi Arabia.
Methods
In a retrospective study, data of 287 kidney transplant recipients, who underwent kidney transplant between January 2017 and May 2020 were collected. Data included demographic characteristic, history of hypertension, diabetes mellitus, coronary artery disease, duration of chronic kidney disease and dialysis therapy, dialysis modality, and type of vascular access. Serum iPTH measured prior to transplant then every 6 months post-transplant for 2 years.
Results
Of 287 kidney transplant recipients: 119 (41.5%) were diabetic and 38 (13.2%) had coronary artery disease. 231 (80.5%) had received living-donor kidneys and 56 (19.5%) were cadaveric recipients. iPTH was before transplant: 82.2±84.2 pmol/L, 1- 6 months: 27.5±31.4, 6-12 months: 28.8±35.9, and 12-24 months: 30.1±43.3. p value <0.001. Figure.1
Persistent hyperparathyroidism was found in 47 (16%) of patients at one year post renal transplant. The presence of diabetes mellitus as well as the duration of dialysis were predicators of persistent HPT. Type of transplant and allograft function did not seem to have any correlation.
Conclusion
In a single center experience, (16%) of kidney transplant patients had persistent HPT and the presence of diabetes mellitus and the duration of dialysis were important risk factors in its development.
iPTH post kidney transplatation